Post translational modifications of connexin 43 in ventricular arrhythmias after myocardial infarction

Fan Yang1, Xiao-Lu Zhang1, Huan-Huan Liu2

  • 1Department of Cardiology, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, 214023, China.

Molecular Biology Reports
|February 23, 2024
PubMed

Insights

Connexin43 (Cx43) dysfunction after myocardial infarction (MI) impairs heart electrical signals, increasing arrhythmia risk. Targeting Cx43 modifications offers a promising strategy for preventing and treating post-MI ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Ventricular arrhythmias are a primary cause of sudden cardiac death post-myocardial infarction (MI).
  • Connexin43 (Cx43) is crucial for cardiomyocyte electrical communication; its dysfunction after MI leads to impaired conduction and arrhythmias.
  • Cx43 undergoes significant remodeling (expression, redistribution) post-MI, compromising intercellular communication and increasing arrhythmia susceptibility.

Purpose of the Study:

  • To review the regulatory mechanisms of Cx43 post-translational modifications in post-MI ventricular arrhythmias.
  • To discuss Cx43-targeted therapies as a potential strategy for managing these arrhythmias.

Main Methods:

  • Literature review focusing on Cx43 regulation and its role in post-MI arrhythmias.
  • Analysis of studies investigating Cx43 post-translational modifications (e.g., phosphorylation, ubiquitination).
  • Examination of therapeutic strategies targeting Cx43.

Main Results:

  • Cx43 remodeling, including altered expression and localization, is a key factor in post-MI arrhythmogenesis.
  • Post-translational modifications critically regulate Cx43 function and stability after MI.
  • Cx43-targeted interventions show potential for preventing and treating ventricular arrhythmias.

Conclusions:

  • Cx43 dysfunction and its post-translational modifications are central to the development of ventricular arrhythmias following MI.
  • Targeting Cx43 represents a promising therapeutic avenue for reducing sudden cardiac death after MI.
  • Further research into Cx43-mediated mechanisms could lead to innovative treatments for post-infarction heart conditions.